Literature DB >> 12674039

Allergy and skin diseases in musicians.

C Lombardi1, M Bottello, A Caruso, S Gargioni, G Passalacqua.   

Abstract

In order to define a standard diagnostic protocol for managing allergic dis-eases in musicians, we conducted a literature search on this topic. The most frequent allergic disease in this special category of workers was contact dermatitis, always described in stringed and wind instruments players, involving the mouth and the hands. No other allergic disease directly related to musical instruments was reported. The most frequently reported culprit substances were: colophony, exotic woods, nickel sulphate, varnishes, and propolis (bee glue). Thus, being contact dermatitis the most frequent disease, a correct diagnostic approach to this problem in musicians should involve, in addition to clinical history and examination, the patch test with a specific panel of substances. Finally, allergy in musicians involves additional problems: the virtual impossibility to avoid the offending substance, and the poor adherence to therapy due to lifestyle. In general, this specific allergologic problem seems to be underestimated, underdiagnosed and, as a conquence, poorly managed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12674039

Source DB:  PubMed          Journal:  Eur Ann Allergy Clin Immunol        ISSN: 1764-1489


  4 in total

1.  Pharmacovigilance--Current and Future Challenges. Abstracts of the International Society of Pharmacovigilance annual conference. Dublin, Ireland, 6-8 October 2004.

Authors: 
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

2.  [Music dermatology].

Authors:  C R Löser
Journal:  Hautarzt       Date:  2015-04       Impact factor: 0.751

Review 3.  Contact dermatitis and other skin conditions in instrumental musicians.

Authors:  Thilo Gambichler; Stefanie Boms; Marcus Freitag
Journal:  BMC Dermatol       Date:  2004-04-16

4.  Assaying environmental nickel toxicity using model nematodes.

Authors:  David Rudel; Chandler D Douglas; Ian M Huffnagle; John M Besser; Christopher G Ingersoll
Journal:  PLoS One       Date:  2013-10-07       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.